The FDA recently approved two new generic versions of Boehringer Ingelheim Pharmaceuticals Inc.'s popular anti-arthritis medication, Mobic. This medication, which treats the symptoms of both osteo- and rheumatoid arthritis, had sales of over a billion dollars in the United States during the last fiscal year. The two generic alternatives, known by the generic name Meloxicam, are produced by the Israeli company Teva Pharmaceutical Industries Ltd and Par Pharmaceuticals Co, Inc, and are available...
Read moreI've been taking Wellbutrin (generic name Bupropion) for about seven years, minus the time I was pregnant with my son. I would say that... Read more »
There is a fascinating, if a bit troubling, controversy going on in England over osteoporosis drugs. Doctors and patients alike -- more... Read more »
It's finally here! Merck's patent on the popular osteoporosis drug Fosamax has run out, and now other companies are offering generic... Read more »
On April 15th, the FDA announced a recall of lansoprazole delayed-release orally disintegrating tablets. These are generic Prevacid (Proton... Read more »
The good news about treating allergies is that there are lots of options. The bad news is that sometimes it takes quite a bit of trial and... Read more »
Drugmakers Atlana and Wyeth have sued Schwarz Pharma to stop the rival company from making a generic form of Protonix (pantoprazole). Schwarz Pharma... Read more »
Drugmaker Wyeth has launched a generic version of their acid-reflux medication Protonix. The launch comes in response to the generic version of... Read more »
Drugmaker Teva has received tentative approval for a generic form of Protonix delayed-release tablets (pantoprazole sodium). Final approval is... Read more »
The U.S. Food and Drug Administration (FDA) has seized all supplies from Michigan-based generic drug maker Caraco, a move that affects 33 medications... Read more »
Don't expect a cheaper alternative to Lipitor--or similar cholesterol-lowering drugs--anytime soon. A U.S. court ruling blocks generic competitors... Read more »